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 NEWS CELL CyCLE NEWS & viEWS
The tumor suppressor p53 is mutated or inac-
tivated by epigenetic mechanisms in more 
than 50% of all human cancers. in resting 
conditions, baseline levels of p53 reportedly 
contribute to the maintenance of homeostasis 
by favoring anti-oxidant mechanisms and by 
regulating energy metabolism.1 in response 
to various types of stress (e.g., DNA damage, 
oncogene deregulation), p53 is subjected to 
multiple post-translational modifications that 
inhibit its degradation by the proteasome 
system, resulting in p53 accumulation at both 
nuclear and extranuclear sites.2 in the nucleus, 
p53 controls a large number of transcriptional 
programs, which can lead to cell cycle block-
age, activation of autophagy or induction of 
apoptotic cell death.2 Cytoplasmic p53 has 
been shown to exert lethal effects by interact-
ing with members of the BCL-2 protein family 
at mitochondria,3 and inhibits autophagy.4 The 
subcellular shuttling of p53 (from the nucleus 
to the cytoplasm and from the cytoplasm to 
mitochondria, and vice versa) is regulated 
by additional post-translational modifications 
including MDM2-mediated (poly)monoubiq-
uitination and HAUSP-mediated deubiquitina-
tion.2 Thus, p53 is at the hub of a complex and 
highly dynamic system that regulates several 
aspects of the cell metabolism.
in Cell Cycle, Grinberg et al. show that 
recombinant wild type (WT) p53 as well 
as cytoplasmic extracts from two distinct 
p53-proficient human cancer cell lines 
(i.e., HCT 116 colon carcinoma and LCC2 
human breast cancer cells) can catalyze the 
removal of nucleotides from the 3’ end of 
both double-stranded and single-stranded 
RNA (dsRNA and ssRNA, respectively).5 This 
enzymatic activity could not be detected 
in lysates from p53-/- HCT 116 cells or from 
p53-null H1299 non-small cell lung cancer 
(NSCLC) cells, and could be prevented by 
pre-incubation of cytoplasmic fractions with 
a p53-neutralizing antibody.5 Moreover, in 
extracts from p53+/+ (but not in p53-/-) HCT 
116 cells, the degradation of dsRNA increased 
when cells were subjected to p53-activating 
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stimuli (e.g., γ irradiation) before lysis. Finally, 
the reintroduction of WT p53 (but not of the 
catalytic dead p53R175H mutant) in p53-defi-
cient HCT 116 cells resulted in the restoration 
of a cytoplasmic dsRNAse activity.5 Altogether, 
the results provided by Grinberg et al. dem-
onstrate that p53 possesses intrinsic 3’→5’ 
exonuclease activity that can actively degrade 
dsRNA substrates in cellula.
dsRNA is a molecular species with mul-
tiple biological functions. Baseline levels of 
endogenous dsRNA participate in physi-
ological processes including gene expression, 
heterochromatin remodeling, RNA editing, 
and translation control by natural antisense 
RNA and microRNA.6 Moreover, high levels 
of dsRNA may be generated from perturba-
tions of the RNA metabolism by genotoxic 
agents, upon aberrant transcription from 
damaged DNA or as a result of viral infection, 
and have been suggested to operate as an 
intracellular danger signal.7 One of the best 
characterized responses to dsRNA accumula-
tion is coordinated by the interferon-induced 
protein kinase RNA-activated (PKR), which 
rapidly shuts off protein translation by phos-
phorylating the α subunit of the eukaryotic 
translation initiation factor 2 (eiF2α). PKR-
mediated eiF2α phosphorylation limits viral 
spreading by blocking translation and partici-
pates (at least in some instances) in the induc-
tion of autophagy, which also operates as 
an antiviral mechanism.7 As cytoplasmic p53 
inhibits autophagy,4,8 the results presented 
in Cell Cycle by Grinberg and co-workers5 
open the fascinating possibility that at least 
part of the autophagy-inhibitory potential of 
p53 might derive from an indirect effect on 
dsRNA-mediated activation of PKR (Fig. 1). 
in this context, however, it should be noted 
that while both WT and mutant (p53R175H) p53 
suppress autophagy when they are localized 
in the cytoplasm,9 only the former exerts 
bona fide dsRNAse activity.5 Still, as both WT 
p53 and p53R175H bind dsRNA with the same 
efficiency,5 it cannot be excluded that p53 (at 
least in part) inhibits autophagy by limiting 
the cytoplasmic availability of dsRNA, thereby 
hindering the dsRNA-mediated activation 
of PKR. Further experiments are urgently 
awaited to elucidate these incognita and to 
evaluate p53’s main function, the mainte-
nance of cellular homeostasis, in view of its 
newly discovered ability to bind and degrade 
dsRNA.
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Figure 1. Cytoplasmic functions of p53 
in relationship to its capacity to bind and 
degrade dsRNA. At least in some instances, 
phosphorylation of the α subunit of the eu-
karyotic translation initiation factor 2 (eiF2α), 
which can be catalyzed by protein kinase 
RNA-activated (PKR), is required for full-
blown autophagy. Wild-type p53 efficiently 
binds to and degrades dsRNA (an activator of 
PKR), which may explain (at least part of) the 
autophagy-inhibitory potential of cytoplas-
mic p53. dsRNAse-deficient p53 mutants (e.g., 
p53R175H) maintain their dsRNA-binding as 
well as their autophagy-inhibitory activity, 
implying that p53-mediated dsRNA seques-
tration might suffice to limit PKR activation 
and hence to inhibit autophagy.
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Schizosaccharomyces pombe gene deletion library nearing completion:  
New perspectives for cell cycle research
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Cell cycle studies in the budding yeast 
Saccharomyces cerevisiae and the fission yeast 
Schizosaccharomyces pombe have contrib-
uted enormously to our understanding of the 
eukaryotic cell cycle. The cell cycles of these 
organisms are currently the best understood of 
all eukaryotes. The genomic-postgenomic era 
has brought with it a basic change in experi-
mentation, enabling researchers to look more 
comprehensively at the regulation and molec-
ular mechanisms operating in the eukaryotic 
cell cycle. One of the “early” breakthrough 
achievements in the Schizosaccharomyces 
pombe post-genomic cell cycle research 
was obtained by genome-wide transcrip-
tion profiling of synchronised cultures, which 
revealed that over 400 genes are periodically 
transcribed.1 These results gave a new impe-
tus to Schizosaccharomyces pombe cell cycle 
research by highlighting the importance of 
certain genes and key regulators, which were 
then subjected to detailed molecular analysis. 
Further progress of similar significance can 
be expected from screening of gene deletion 
libraries (“deletomes”) consisting of deletion 
mutants each of which possessing a different 
ORF/gene deletion.
in the budding yeast Saccharomyces cerevi-
siae such collections of mutants have already 
been successfully used in the investigation of 
the cell. in a recent study, a quantitative flow 
cytometry assay was used to screen a large 
set of mutants with single deletions in genes 
coding for known or putative transcription 
factors.2 Twenty percent of the nonessential 
transcription factors turned out to play some 
role in cell cycle. However, mutants often have 
complex phenotypes because many genes 
are indirectly involved in multiple processes. 
One approach for discovering indirect func-
tions and interactions with other genes (or 
proteins) is to combine the mutant allele of 
interest with arrayed gene deletion libraries 
(Synthetic Genetic Array, SGA),3 and ask which 
combination of alleles leads to lethality or a 
new, synthetic phenotype. The SGA approach 
can be refined by combination with specific 
screening methods. A very recent report on 
its combination with a high-content screening 
(HCS) system identified 182 mutations that 
influenced spindle dynamics, 90 of which had 
defects apparent only in the double mutant 
backgrounds.4 interestingly, the screen identi-
fied numerous genes whose links to spindle 
regulation is difficult to understand mecha-
nistically from their annotated functions (e.g., 
metabolism and ribosome biogenesis). These 
findings confirmed the complexity of the regu-
lation of spindle formation and demonstrated 
the power of the deletome-based approach in 
cell cycle research.
The Schizosaccharomyces pombe cell cycle 
research has profited less from gene deletion 
libraries because the systematic deletion of 
all ORFs of the genome lagged behind the 
Saccharomyces cerevisiae deletion project. A 
genome-wide haploid and diploid deletion 
library was only constructed and made avail-
able recently by the Bioneer corporation and 
the Korea Research institute of Biotechnology 
and Bioscience (http://pombe.bioneer.co.kr/). 
This library contains 4,836 diploid heterozy-
gous deletion strains covering 98.4% of the 
organism’s open reading frames.5 However, 
the PCR-based technology6 applied failed to 
delete certain ORFs. in Cell Cycle, Spirek et al.5 
report on the application of a different strat-
egy which is suitable for deletion of genes 
which require large regions of homology. This 
strategy enabled them to create 29 novel 
deletion strains which were missing in the 
Korean library. This extension of the collection 
increased the coverage of the genome to 99%. 
The nearly complete library will surely be a valu-
able resource for functional genomics and cell 
cycle research in Schizosaccharomyces pombe. 
The application of the incomplete library has 
already led to the identification of novel genes 
involved in the DNA damage response, among 
them 23 ORFs which had previously been clas-
sified as “sequence orphans” or as “conserved 
hypothetical” genes.7 When considering the 
significance of a Schizosaccharomyces pombe 
deletion library, one has to bear in mind that 
Schizosaccharomyces pombe is not just another 
yeast. Any experiment to be performed with 
this library will be much more important than 
a simple repetition of an experiment done with 
S. cerevisiae because these two species are 
almost as distantly related to each other as to 
animals8 and their cell cycles are very different.9
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A role for Cdk4 in angiogenesis
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The mammalian cell cycle is directed in part by 
cyclins and their associated serine-threonine 
kinases, termed cyclin-dependent kinases, or 
Cdks. Cdk4, in conjunction with the D-type 
cyclins (cyclin D1, D2 and D3), mediates pro-
gression through the G1 phase when the cell 
prepares to initiate DNA synthesis. Activation 
of Cdk4/cyclin D complexes contributes to 
hyperphosphorylation of the retinoblastoma 
(Rb) and subsequent release of the E2F tran-
scription factor. Once the cell has made the 
G1/S transition, Cdk4 activity is negatively reg-
ulated by iNK4 inhibitors that act by binding 
directly to Cdk4 and preventing D-type cyclin 
activity.1
Alterations in cell cycle progression can 
have far-reaching and sometimes-detrimental 
effects, including deregulated proliferation of 
tumor cells. Amplification and/or overexpres-
sion of the Cdk4 locus has been detected 
in various tumor types, including sarcomas, 
gliomas, breast tumors, lymphomas and mela-
nomas and this overexpression correlates with 
increased Cdk4 activity.1 A missense mutation 
in the Cdk4 gene (R24C) that confers resistance 
to iNK4 inhibitors has also been observed in 
a small percentage of familial melanomas.2,3 
Mice that are homozygous for this mutation 
develop malignancies of varying types such as 
insulinomas, tumors of the breast, liver, pitu-
itary, Leydig cells, skin (carcinogen-induced) 
and gut and therefore serve as an excellent 
model to study the role that Cdk4 plays in 
tumorigenesis.4,5
Tumor progression in colorectal cancer is 
measured by several parameters, including 
vascularity, and the extent to which these 
tumors are vascularized can sometimes pre-
dict the likelihood of recurrence following 
therapy. Angiogenesis, or the formation of 
new blood vessels from those that already 
exist, is critical for tumor progression as it 
provides the tumor with the means by which it 
can acquire the oxygen and nutrients that are 
required for growth.6 Although the factors that 
regulate this process are often secreted by the 
tumor itself, their expression and the events 
that control angiogeneic-associated prolifera-
tion are linked to the cell cycle.
in their recent work, Abedin et al. report that 
Cdk4 regulates colorectal tumor angiogene-
sis.7 Min mutant mice harbor a mutation in the 
adenomatous polyposis coli (Apc) gene that is 
most commonly mutated in human colon can-
cers. Depending on the genetic background, 
heterozygous mice develop intestinal adeno-
mas by 3–6 months of age and when crossed 
with Cdk4R24C mice (Cdk4R24C/R24C:Apc+Min), 
develop intestinal and colon tumors that are 
highly vascularized with red blood cells in 
the lumen of the blood vessels.7 Although it 
is not surprising that this phenotype mirrors 
that obtained in colorectal tumors isolated 
from Min-heterozygous/ink4a null-mutant 
(Ink4a-/-:Apc+Min) mice,8,9 this study, for the first 
time, provides evidence that supports the 
direct involvement of Cdk4 in this process.
One important question to ask from a 
mechanistic perspective is: How does Cdk4 
regulate angiogenesis? A logical answer and 
one that is supported by the data is that con-
stitutive activation of Cdk4 results increased 
levels of E2F activity. Cdk4R24C/R24C:Apc+Min 
tumors express high levels of vascular endo-
thelial growth factor-B (vEGF-B) and fibroblast 
growth factor-2 (Fgf-2), both of which are 
E2F-target genes. They also express elevated 
levels of cyclin A, which is also a target of E2F.7 
Although a role for cyclin A in angiogenesis 
has not been established, it is possible that 
this increase in expression may mediate some 
of the events that are associated with the 
formation of new blood vessels. However, the 
role of cellular proliferation in Cdk4-mediated 
angiogenesis is still not well defined. it is of 
interest to note that Cdk4R24C/R24C:Apc+Min mice 
have neither a higher tumor incidence nor 
an increase in tumor volume when compared 
to mice that are wild-type at the Cdk4 locus. 
This is again similar to what is observed in 
Ink4a-/-:Apc+Min mice where there was also no 
significant increase in tumor cell proliferation.9 
While genetic targeting of Cdk4 in mice has 
revealed that the gene is not essential for cell 
cycle progression, it is required for the prolif-
eration of certain cell types such as pancreatic 
β-cells.10 Considering that Cdk4 is required 
for Neu- and Ras-induced breast tumorigen-
esis,11,12 future studies aimed at determining 
whether loss of Cdk4 has any effect on colorec-
tal tumor development and angiogenesis will 
certainly be of significance, especially if one 
is to consider the use of Cdk4-inhibitors in 
cancer therapy.
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FANCs regulate firing of DNA replication origins
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Firing of DNA replication origins on the 
eukaryotic chromosomes is both spatially and 
temporally regulated and this regulation may 
be closely associated with control of gene 
expression as well as separation of chromo-
some domains in the nucleus.1 Eukaryotic 
DNA replication proceeds in two steps; first 
assembly of pre-replicative complex (pre-RC) 
at presumptive origins in early G1 followed 
by “activation” of selected pre-RC (“firing”) 
through association of other replication fac-
tors including Cdc45 to generate active rep-
lication forks. The firing step requires actions 
of Cdk and Cdc7 which phosphorylate pre-RC 
components. However, the precise mechanism 
of maturation of pre-RC into an active replica-
tion fork structure has been elusive.
in Cell Cycle, Song and colleagues in the 
laboratory of Cyrus vaziri at the University of 
North Carolina reported the unexpected par-
ticipation of additional proteins in this com-
plex process.2 These workers evaluated the 
roles of FANCD2, the effector of the Fanconi 
Anemia (FA) DNA repair pathway in cell cycle 
progression of cultured human cells. They 
observed that DNA replication is significantly 
compromised in cells depleted of FANCD2. 
The requirement of FANCD2 for efficient DNA 
replication was observed not only in cancer 
cell lines but also in untransformed primary 
cells. in cells released from quiescence, both 
onset of the S phase and S phase progres-
sion were delayed after depletion of FANCD2. 
Detailed analyses of the distinct stages of DNA 
replication using velocity sedimentation of 
nascent DNA and DNA fiber studies showed 
that DNA chain elongation is not affected 
by FANCD2 depletion, but that the number 
of initiation events is reduced in FANCD2-
deficient cells. Moreover, FANCD2 associates 
in a complex with Cdc45 specifically in the 
chromatin fraction and chromatin loading of 
the initiation factor Cdc45 is downregulated 
in FANCD2-depleted cells, further consistent 
with a role for FANCD2 in origin firing. Other FA 
proteins including FANCA, FANCG and FANCi 
involved in FANCD2 monoubiquitination are 
also required for efficient DNA replication, 
suggesting that the monoubiquitination plays 
a critical role in FANCD2-mediated promotion 
of DNA replication.
Previous studies with replication-compe-
tent Xenopus egg extracts have also indi-
cated a role for FANCD2 in DNA replication.3 
in those studies, the FA pathway was pro-
posed to mediate processing and repair of 
replication-associated DNA damage.3 Similar 
to replicating Xenopus egg extracts, associa-
tion of FANCD2 with chromatin in human cells 
is dependent on DNA replication. However, 
because a DNA damage response was not 
detected in FANCD2-depleted S-phase cells,2 
the FA pathway may not play a major role 
in repair of replication-associated DNA dam-
age in human cells. instead, in human cells 
FANCD2 may be required specifically for 
the activation of pre-RC through loading of 
Cdc45. The newly-described requirement of 
FANCD2 for initiation of DNA replication may 
explain the poor growth phenotype of FA 
patient cell lines.
The findings in this report raise new ques-
tions regarding the relationship between the 
FA pathway and the DNA replication machin-
ery. How and when does FANCD2 associate 
with chromatin? What exactly is the role of 
FANCD2 in activation of pre-RC? Does FANCD2 
directly interact with Cdc45? What is the role of 
FANCD2 monoubiquitination in this process? 
Following DNA damage or during S phase, 
the FA core complex becomes activated and 
monoubiquitinates FANCD2. This monoubiqui-
tination has been suggested to target FANCD2 
to chromatin where it interacts with other 
DNA repair proteins.4 However, the mecha-
nism for chromatin association of FANCD2-Ub 
remains unclear. One major hypothesis is that 
a ubiquitin-interacting motif (UiM)-containing 
protein, which localizes in chromatin, serves 
as a receptor for FANCD2-Ub.4 Thus, factors in 
the pre-RC or the initiation complex could be 
candidates for the putative FANCD2-Ub recep-
tor. FANCD2-Ub is not detected on chromatin 
until the G1/S transition, suggesting that an S 
phase initiation signal may be required for this 
chromatin binding. Cdc7 kinase is required for 
firing at pre-RC and it would be interesting 
to examine whether chromatin binding of 
FANCD2 depends on Cdc7.
During serum starvation (G0/G1 phase), the 
level of FANCD2 is significantly reduced, and 
following re-stimulation with serum (entry into 
cell cycle), FANCD2 expression increases and 
is maintained during S phase. interestingly, 
FANCD2 protein levels decrease in GiNS-
depleted cells.2 is FANCD2 stabilized upon ini-
tiation of DNA replication? The ubiquitinated 
FANCD2 (chromatin-bound FANCD2) may be 
more stable than the unmodified form.
The FA pathway is activated in an ATR-
dependent manner following replication fork 
stalling.5 Direct phosphorylation (SQ/TQ) of 
FANCD2 (and FANCi) by ATR or ATM has been 
well studied and appears to promote FANCD2 
monoubiquitination in response to DNA dam-
age.4 it is possible that, even during the course 
of unperturbed cell cycle progression, the 
FA pathway is weakly activated in an ATR-
dependent fashion during initiation of replica-
tion, thereby facilitating FANCD2 loading onto 
the pre-RC and promoting chromatin bind-
ing of Cdc45 or stabilization of the initiation 
complex. Once associated with the activated 
pre-RC, FANCD2 itself may also be stabilized. 
Elucidation of mechanisms by which FANC 
proteins participate in DNA replication cer-
tainly deserves further experiments not only 
to understand the molecular basis for the 
pathology of FA, but also to uncover addi-
tional layers of regulation that lead to timely 
and efficient initiation of DNA replication in 
vertebrates.
Acknowledgements
i would like to thank Dr. Jung-Min Kim for valu-
able comments on the manuscript.
References
1. Masai H, et al. Ann Rev Biochem 2010; 79:89-130.
2. Song Jy, et al. Cell Cycle 2010; 9:2375-88.
3. Sobeck, et al. Mol Cell Biol 2006; 26:425-37.
4. Moldovan GL, et al. Annu Rev Genet 2009; 
43:223-49.
5. Andreassen PR, et al. Genes Dev 2004; 18:1958-63.
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ity
 of
 Sz
eg
ed
] a
t 0
5:3
6 0
4 N
ov
em
be
r 2
01
5 
www.landesbioscience.com Cell Cycle 2495
Breaking into the brachyury world: DNp63 joins in 
Comment on: Cho MS, et al. Cell Cycle 2010; 9:2434–41.
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regulated transcription factors, which act 
together with ΔNp63 in mediating some of 
the biological functions of p63. The paper 
by Elsa Flores and colleagues in Cell Cycle 
addresses this issue by demonstrating that the 
archetypal T-box family member brachyury is a 
direct DNp63 target.6
The initial evidence hinting that brachyury 
might be specifically regulated by p63 and not 
its family members, p53 and p73 came from 
global microarray analysis of mouse embry-
onic fibroblasts (MEFs) deficient for each p53 
family member.7 Given that brachyury and 
p63 share overlapping expression profiles dur-
ing mouse embryonic development, in par-
ticular in the AER, the authors reasoned that 
brachyury could be downstream of the p63 
pathway. indeed, expression of brachyury was 
considerably attenuated in p63 null animals 
lacking both ΔNp63 and TAp63 as opposed 
to animals missing TAp63 alone. Armed with 
this piece of data, the authors then performed 
chromatin immunoprecipation experiments 
to show that ΔNp63 bound to a specific p63-
Response Element (p63-RE) present in the 
proximal promoter region of the brachyury 
(T) gene. interestingly, p53 and p73 did not 
occupy this site in vivo further supporting 
the notion that despite similarities in DNA-
recognition elements, binding of p53 family 
members to their target elements is governed 
by additional factors. To further verify the 
importance of this p63-RE, the authors per-
formed reporter assays in MEFs deficient in 
both p53 and p63. As expected, the segment of 
the brachyury promoter containing the p63-RE 
was strongly transactivated by ΔNp63 and not 
TAp63 and this response was mitigated when 
the p63-RE was mutated. interestingly, the 
ability to activate the brachyury promoter was 
restricted to only the ΔNp63α and ΔNp63β iso-
forms, while the ΔNp63γ protein did not show 
any activity. This result is in sharp contrast to 
prior studies where the shortest ΔNp63γ iso-
form have been shown to possess similar if not 
higher transcriptional activity when compared 
to ΔNp63α and ΔNp63β. Possible explana-
tions for this difference include cell type con-
text, the varying nature of the p63-RE being 
studied and the usual caveats associated with 
The crucial role of the transcription factor 
Trp63 in regulating various facets of epithelial 
development and differentiation is epitomized 
by the striking phenotype of the p63 knockout 
mice.1-2 These animals have a denuded skin 
bereft of a mature stratified epidermis and 
aplasia of multiple ectodermal appendages 
such as mammary glands, hair and teeth. This 
phenotype strongly suggests that develop-
mental processes that rely heavily on proper 
epithelial-mesenchymal interactions are 
particularly affected in the absence of p63. 
Consistent with this view, p63-null animals 
also suffer from severely arrested limb devel-
opment due to the physical and functional 
impairment of the Apical Ectodermal Ridge 
(AER). Deciphering the underlying molecular 
mechanism by which p63 transcriptionally 
regulates these developmental processes has 
proven to be quite challenging, in part, due to 
the existence of a growing number of p63 iso-
forms. Broadly, p63 isoforms can be grouped 
into two major classes: TAp63 isoforms that 
contain an N-terminal transactivation domain 
and ΔNp63 isoforms, which lack this domain. 
Furthermore, alternative splicing generates 
various C-terminal variants representing long 
(p63α) or short (p63β and γ) isoforms, each 
of which display distinctive biochemical and 
functional properties. 
Since the established p63 mouse knockout 
models lack both TA and ΔNp63, it has been 
difficult to ascertain the relative contribution 
of these isoforms to the observed phenotype. 
However, recent studies have strongly sug-
gested that ΔNp63 and not TAp63 isoforms 
are predominantly expressed in most epithe-
lial cells, and hence likely to be functionally 
more relevant—a view that is strengthened by 
the paucity of any developmental phenotype 
in the TAp63 specific knockout animals.3-5 in 
addition, contrary to previous assumption that 
ΔNp63 might function primarily as a domi-
nant negative, the current consensus is that 
ΔNp63 is a potent transcriptional regulator on 
its own right and can regulate distinct sets of 
target genes and dictate a stratified epithelial 
identity.3,5 Hence, there is an emerging need 
for identifying specific molecular targets of 
ΔNp63, particularly other developmentally 
transient transfection experiments with artifi-
cial reporter constructs.
Another aspect of the ΔNp63-brachyury 
connection tackled in this paper deals with the 
putative oncogenic roles of these two factors. 
indeed high levels of both ΔNp63 and brachy-
ury have been detected in several human 
cancers. in agreement with this, the authors 
found that in osteosarcoma (Os) cell lines, the 
transcripts for ΔNp63 and brachyury showed 
concordant expression with high levels of 
ΔNp63 accompanied by high levels of brachy-
ury. importantly knockdown of ΔNp63 in the 
Os cell lines with high levels of ΔNp63 resulted 
in dramatic reduction in brachyury mRNA and 
conversely, overexpression of ΔNp63α and 
ΔNp63β in ΔNp63-low cell lines drove the 
endogenous levels of brachyury higher. Finally, 
the authors show that the diminished levels 
of ΔNp63 and consequently brachyury in the 
Os cells treated with siRNA against ΔNp63 
resulted in decreased cell proliferation, migra-
tion and invasion behavior. On one hand, this 
result fits well with a recent report showing 
that brachyury inhibition in human lung car-
cinoma cells results in loss of mesenchymal 
markers and reduced migration and invasion 
of human lung carcinoma cells.8 On the other 
hand, the decreased migration and invasion 
behavior of Os cells upon loss of ΔNp63 is 
quite surprising given that in most epithelial 
cells, knockdown of ΔNp63 is accompanied by 
a shift towards mesenchymal morphology and 
an increase in motility.9 This discrepancy most 
likely reflects the disparate nature of the origin 
of the cell types (carcinoma vs sarcoma for e.g) 
chosen for these experiments.
The findings by Cho et al. establishes a new 
candidate in the ΔNp63-regulated transcrip-
tional landscape and like most studies also 
raises several interesting questions, which are 
likely to spur new avenues of future research. 
it is important to note that brachyury is highly 
expressed in chordoid tumors and a recent 
study has established that brachyury gene 
duplication confers major susceptibility to 
familial chordoma, a rare bone cancer believed 
to originate from notochordal remnants.10 
One tantalizing prospect is that high levels 
of ΔNp63 might affect tumors with chordoid 
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features or those of mesenchymal origin by 
influencing brachyury levels. The ΔNp63-
brachyury nexus hence may be relevant for a 
spectrum of human cancers that express high 
levels of these transcription factors and offer 
new targets and strategies for therapy. 
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Kip3 clusters kinetochores
Comment on: Wargacki M, et al. Cell Cycle 2010; 9:2581–8. 
Rania S. Rizk and Mohan L. Gupta, Jr.; University of Chicago; Chicago, IL, USA; Email: mlgupta@uchicago.edu 
During mitosis chromosome segregation 
relies on the action of microtubules within the 
mitotic spindle. Each chromosome is attached 
to spindle microtubules via its sister kineto-
chores, the proteinacious complexes found 
at opposite sides of its centromere.1 The sub-
set of microtubules that becomes attached 
to the kinetochores is referred to as kineto-
chore microtubules (kMTs).  While each kineto-
chore attaches to ~25 microtubules in higher 
eukaryotes,2 the budding yeast kinetochore 
binds only a single microtubule.3 Chromosome 
movement is coupled to kMT polymeriza-
tion/depolymerization dynamics. During 
metaphase, as sister kinetochores establish 
bipolar attachments with dynamic kMTs, chro-
mosomes are congressed and aligned at the 
center of the spindle.1  in budding yeast, 
congression clusters the sister kinetochores in 
two regions on either half of the spindle.4 The 
mechanism(s) regulating the dynamics of indi-
vidual kMTs to attain metaphase chromosome 
congression remains largely unclear.
Cells utilize motor proteins to facilitate 
and coordinate mitotic events.  Kinesin-8 is 
a conserved subclass of Kinesin microtubule 
motors that regulates microtubule dynam-
ics in diverse organisms. When Kinesin-8 is 
knocked-down in higher eukaryotic cells chro-
mosomes are unable to achieve metaphase 
congression resulting in failure to enter ana-
phase and mitotic arrest.5, 6 The budding yeast 
Kinesin-8, Kip3, functions both as a conven-
tional plus-end directed motor and a plus-end 
specific microtubule depolymerase.7, 8 yeast 
cells lacking Kip3 do not arrest in mitosis, 
suggesting that Kip3 is not essential for estab-
lishing bipolar sister kinetochore attachments 
and/or alignment prior to anaphase onset. 
However, recent work by Wargacki and col-
leagues9 provides evidence that Kip3 function 
is important to achieve proper kinetochore 
clustering during metaphase. 
imaging fluorescently-tagged kinetochores 
in live yeast cells, Wargacki et al.9 observed 
variability in kinetochore positioning along 
the spindle axis in the absence of Kip3. One 
possibility is that Kip3 uses its length-depen-
dent microtubule depolymerization activity8 
to ensure that the kMTs of sister kinetochores 
are of equal length. This would in turn cluster 
sister kinetochores equidistant from either 
spindle pole. Paradoxically the authors report 
a decrease in kMT length in the absence of 
Kip3, and it remains unresolved how the loss 
of this depolymerase results in shorter kMTs. 
Movement and congression of chromo-
somes requires coordination between the 
dynamic states of sister kMTs. interestingly, 
Wargacki and colleagues9 find that the shorter 
kMTs are accompanied by increased inter-
kinetochore distance, which may reflect 
perturbed tension at kinetochore-microtu-
bule attachments. Kip3 may therefore play 
a role in coordinating sister kinetochore 
directional movement by correlating kMT 
dynamics with the amount of tension and/
or compressive forces experienced at either 
kinetochore.  Presumably such coordination 
in higher eukaryotes must be extended to all 
~25 microtubules at each kinetochore rather 
than the single kMT found in budding yeast. 
Perhaps the complexity in synchronizing large 
numbers of kMTs is one reason why higher 
eukaryotes display more adverse metaphase 
defects than do budding yeast following per-
turbation of Kinesin-8. However, the molecular 
mechanism(s) through which Kip3 controls 
the dynamics of individual kMTs remains to be 
determined.
in previous work, Tytell and Sorger10 
observed an increase in lagging chromatids 
during anaphase and that a subset of chro-
matids experienced prolonged interruptions 
during anaphase poleward movement in cells 
lacking Kip3. Based on these and other findings 
Tytell and Sorger10 concluded that Kip3 facili-
tates the synchronous anaphase movement of 
chromatids toward the spindle poles, a process 
intimately connected to kMT depolymeriza-
tion. in light of the current study, Wargacki and 
colleagues9 propose that defects in kineto-
chore clustering and the resulting disparate 
starting positions upon anaphase onset may 
be the major cause of the lagging anaphase 
chromatids. While the failure to congress could 
explain in large part the accumulation of lag-
ging chromatids, it does not directly account 
for discontinuous poleward movement unless 
unclustered chromatids also experience sub-
sequent problems with anaphase movements. 
As it stands, it would appear that Kip3 dis-
tinctly functions in metaphase to cluster chro-
matids and in anaphase to facilitate poleward 
chromatid movement. Determining the over-
lap between Kip3 function during metaphase 
and anaphase may be particularly tractable in 
budding yeast because the loss of Kip3 does 
not prevent progression into anaphase.
Overall, these findings highlight the con-
served role of Kinesin-8 in chromosome con-
gression across different systems and raise 
interesting questions about the mechanisms 
underlying the role of Kip3 in regulating kine-
tochore clustering.
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Kip3-ing kinetochores clustered
Comment on: Wargacki M, et al. Cell Cycle 2010; 9:2581–8. 
Ryoma Ohi; Vanderbilt University Medical School; Nashville, TN, USA; Email: ryoma.ohi@vanderbilt.edu 
Metaphase is the brief and highly conspicuous 
period during cell division where chromo-
somes become positioned at the spindle equa-
tor through the process of “congression”. it is 
generally believed that congression promotes 
accurate chromosome segregation during 
anaphase, and this logic has driven research 
over several decades to identify the underly-
ing mechanisms. Recent studies have demon-
strated that Kinesin-8 microtubule motors are 
important for congression in organisms rang-
ing from fission yeast to humans,1-3 and that 
they probably act by modulating the dynamics 
of kinetochore-microtubule plus ends where 
they concentrate.2,4-6 it has been unclear, how-
ever, if this role is conserved in the budding 
yeast Saccharomyces cerevisiae. Previous work 
by Tytell and Sorger showed that kinetochores 
lag during mitosis in yeast cells lacking the 
Kinesin-8 Kip3, and they proposed that Kip3 
synchronizes poleward kinetochore move-
ments during anaphase.7 Gardner et al. have 
suggested that Kip3 is not involved in kineto-
chore positioning during pre-anaphase mito-
sis, and that the primary function of Kip3 is 
to govern spindle length by regulating the 
dynamics of interpolar microtubules.8
in Cell Cycle, Wargacki and colleagues dem-
onstrate that Kip3 is required for chromosome 
congression like other Kinesin-8 motors.9 in 
budding yeast, metaphase sister kinetochores 
appear bi-lobed, forming clusters on either 
side of the spindle equator. Using quanti-
tative fluorescence microscopy and live cell 
imaging, the authors find that kinetochores 
attach spindle microtubules normally in 
kip3Δ cells but are declustered (Fig. 1), indi-
cating that kinetochores are scattered along 
the spindle axis in the mutant. This notion is 
confirmed through an analysis of single cen-
tromere (CEN3) positioning. Wargacki et al. 
show that KiP3 deletion causes CEN3 
mis-positioning and, consistent with 
previous work,7 that centromeric chro-
matin between sister kinetochores is 
hyperstretched, an effect probably 
caused by abnormally high microtu-
bule-induced pulling forces on kineto-
chores. A final important observation 
in the Wargacki et al. study is that 
spindle length is normal in kip3Δ 
cells, suggesting that Kip3-dependent 
effects on kinetochore positioning are 
not indirect consequences of inter-
polar microtubule length regulation 
by the motor. Discrepancies between 
previous reports8,10 are probably due to tech-
nical differences in how spindle lengths were 
measured; Wargacki et al. used spindle pole 
body markers instead of fluorescent tubulin to 
identify spindle poles.
The work by Wargacki et al. is important 
because it establishes that Kip3, like the 
other Kinesin-8 motors analyzed to-date, per-
forms a critical function during chromosome 
congression. it also supports the idea that 
proper kinetochore positioning during meta-
phase contributes to the accuracy of sister 
chromatid segregation during anaphase. As 
Wargacki et al. point out, sister chromatids 
will be scattered along the anaphase spindle 
if they initiate poleward movements from het-
erogeneous positions, reasoning which might 
account for the lagging chromosomes previ-
ously observed by Tytell and Sorger.7 The next 
challenge is to define how Kip3 influences 
kinetochore positioning, and how this activ-
ity is integrated with other major chromo-
some positioning factors such as Kip1 and 
Cin8.7,8 in vitro, Kip3 is a plus end-directed 
microtubule depolymerase that is capable of 
destabilizing filaments assembled from the 
GTP-mimic GMPCPP.5,6 it is unclear, however, 
how loss of Kip3 would lead to increased pull-
ing forces on kinetochores, a phenotype that 
suggests that Kip3 antagonizes microtubule 
shortening. At kinetochore-microtubule plus 
ends, Kip3 might act via other mechanisms to 
control kinetochore movements, as recently 
suggested for its human orthologue Kif18A.4 
Future work is needed to reveal the precise 
mechanism(s) by which Kinesin-8 proteins 
govern kinetochore movements and their 
overall positioning during mitosis.
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Figure 1. Kinetochores fail to congress in kip3∆ cells.
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Novel insights into the cytoplasmic functions of p53
Comment on: Grinberg S, et al. Cell Cycle 2010; 9:2442–55 
Frauke Goeman and Giovanni Blandino; Italian National Cancer Institute; Rome, Italy; Email: blandino@ifo.it 
The tumor suppressor protein p53 plays a 
pivotal role in preventing malignant develop-
ment. Approximately 50% of all human tumors 
harbor an inactivating mutation, many others 
show a compromised function by elevation 
of its inhibitors, reduction of its activators, 
or inactivation of downstream targets.1 Most 
studies so far focused on the transcriptional 
activities of p53 which allow the “guardian 
of the genome” to govern life and death of 
cells by regulating cell cycle arrest, senes-
cence, apoptosis, changes in metabolism, and 
others either via transcriptional activation or 
repression. The ability of p53 to bind directly 
to specific DNA sequences and transactivate 
nearby genes is the capacity that distinguishes 
wild-type p53 from virtually all cancer associ-
ated mutant forms.2 Despite its transcriptional 
properties p53 was shown to play a role in DNA 
replication and homologous recombination.1 
An emerging area of research reveals that 
p53 possesses also functions outside of the 
nucleus. A cytoplasmic pool of p53 can acti-
vate apoptosis by directly targeting mito-
chondria for cell death induction.3 Another 
cytoplasmic property of basal p53 levels is 
its ability to inhibit autophagy.4 inhibition of 
autophagy under inappropriate conditions 
can be oncogenic. in line with that, autophagy 
has been reported to contribute to apopto-
sis and the clearance of damaged proteins 
and organelles. Therefore, it is not surprising 
that stress-activated wild-type p53 can switch 
to the induction of autophagy by stimulat-
ing the transcription of positive autophagy 
regulators.5 in contrast, several cancer-associ-
ated p53 mutants that lost their transactivat-
ing activity retained their ability to inhibit 
autophagy.6 
The control of centrosome replication 
displays another cytoplasmic effect of p53.1 
interestingly, cytoplasmic p53 was shown to 
control the translation of certain mRNA tran-
scripts and possess 3’→ 5’ exonuclease activity 
of DNA and ssRNA.7 
Grinberg et al. in Cell Cycle now adds a new 
facet to the growing complexity of p53. The 
authors could show that p53 exerts also 3’→ 
5’ exonuclease activity towards dsRNA. dsRNA 
plays a role in various important biological 
processes like gene activation, heterochroma-
tin remodelling, RNA-editing, iFN responses 
and translation control mediated by natu-
ral antisense RNA and microRNA.8 p53 was 
shown to play a role in the host defence 
against viral infections by its ability to directly 
activate the transcription of dsRNA-activated 
protein kinase (PKR) leading to translational 
inhibition and cell apoptosis.9 Grinberg et al. 
now showed evidences that p53 might also 
directly provide antiviral function by its dsRNA 
exonuclease activity. PKR is activated by low 
concentrations of dsRNA longer than 30bp, 
but inhibited by high amounts. Therefore, the 
dsRNA exonuclease activity of p53 could also 
alter the levels or length of dsRNA and there-
fore the response of PKR versus translational 
inhibition and apoptosis. 
Even more interesting is the potential 
impact of p53 on the RNAi and microRNA 
machinery which might open a plethora of 
new p53 functions. 
Notably, the gain-of function mutant 
p53-R175H did not exhibit exonuclease activ-
ity, so the question is if and how this nuclease 
cleavage activity contributes to the tumor 
suppressor functions of p53. it will be interest-
ing to test also other mutants, taking loss-of-
function and gain-of-function, DNA-contact 
and conformational mutants into the analysis. 
The authors showed that irradiation increased 
the stability and therefore the amount 
of nuclear but also cytoplasmic p53 with a 
subsequent increase of cytoplasmic dsRNA 
3’→ 5’ exonuclease activity. it might be inter-
esting to test if sub-apoptotic and apoptotic 
stimuli or different posttranslational modifica-
tions of p53 provoke differences in its dsRNA 
3’→ 5’exonuclease activity. 
The ssRNA 3’→ 5’exonuclease activity of 
p53 showed a kind of sequence specificity, 
being permissive to RNA containing AU-rich 
elements which is a destabilizing sequence 
often found in proto-oncogene and cytokine 
mRNAs characterized by a short half live.7 
it will be challenging to investigate fur-
ther whether the dsRNA exonuclease 
activity of p53 has some kind of sequence 
specificity or preference or if it rather displays 
a general mechanism for viral defence and PKR 
regulation. 
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Figure 1. Overview of p53 activities in the nucleus and in the cytoplasm; MOMP (mitochon-
drial outer membrane permeabilization). 
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Integration of transcriptional signals at the tumor cell invasive front
Comment on: Fuxe J, et al. Cell Cycle 2010; 9:2363–74
Erik Meulmeester and Peter ten Dijke; Leiden University Medical Center and Uppsala University and Ludwig Institute for Cancer Research; Leiden and Uppsala,  
The Netherlands and Sweden; Email: p.ten_dijke@lumc.nl 
Cancer is one of the world wide leading causes 
of death, of which the mortality rate is in 
large part due to metastasis. However, the 
molecular mechanisms that determine the 
spread of tumor cells to distal organs are not 
well understood. The process that leads to 
metastasis is multifaceted and involves a series 
of steps that include: invasion into adjacent 
tissue, intravasation, transport through the cir-
culatory system, extravasation and growth in a 
distal organ.1 Despite the clinical importance, 
the genetic and biochemical determinants 
remain marginally defined. An important pro-
cess that contributes to migration and inva-
sion of tumor cells is thought to be epithelial 
to mesenchymal transition (EMT), when the 
polarity of epithelial tumor cells is disrupted 
and cells take on a mesenchymal spindle-
shape morphology.2
EMT in cancer cells; 
From skepticism to acceptance
EMT is a critical process during development 
that determines the body plan and is char-
acterized by a loss of epithelial cell-cell junc-
tion proteins, such as E-cadherin and zona 
occludens (ZO-1) and at the same time acquire 
the expression of fibroblasts markers, such 
as vimentin and fibroblast-specific protein-1 
(FSP-1). Upon EMT cells become highly motile 
and invasive, allowing survival in an anchor-
age-independent environment and providing 
them with stem cell-like properties (Figure 1).2 
Whereas EMT in specific developmental pro-
cesses is broadly accepted, its functional role 
in cancer biology was initially met with skepti-
cism, mainly due to the absence of convincing 
evidence in clinical samples.3 The epithelial to 
mesenchymal transition is difficult to capture 
in fixed tumor biopsies of cancer patients, par-
tially due to its transient nature as well as that 
tumor cells after EMT are difficult to be dis-
tinguished from stromal cells or other tumor 
associated fibroblasts. However, EMT in cancer 
has recently gained in acceptance and has 
been observed in patient tumor samples, in 
particular at the invasive front of solid tumors.4 
Interplay TGF-β and cancer stem cell 
pathways
in Cell Cycle, Fuxe et al. review the current 
knowledge of signaling pathways that are 
fundamental for EMT of cancer cells.5 A mayor 
inducer of the dedifferentiating EMT process 
is the transforming growth factor (TGF)-β sig-
naling pathway.6 The signal is transduced by 
members of the Smad family that are the 
transcriptional effectors of TGF-β. Since the 
intrinsic DNA binding activity of Smads is 
weak, they need to cooperate with other part-
ner transcription factors to regulate gene tran-
scriptional responses.7 Fuxe et al. elegantly 
discuss the emerging concept that TGF-β sig-
naling and cancer stem cell pathways, such as 
Ras, Wnt, Hedgehog and Notch are intimately 
linked for the induction of EMT at tumor inva-
sive niches. Transcriptional Smad containing 
complexes, termed EMT promoting Smad 
complexes (EPSC) by Fuxe et al., have a key 
role in the integration of external and internal 
cues that control EMT.5 An important external 
trigger for EMT that needs further dissection 
in future studies is the inflammatory tumor 
microenvironment. What is not discussed in 
the review by Fuxe et al. is the important role 
of non-Smad signaling pathways downstream 
of TGF-β receptors in controlling epithelial 
plasticity by inducing a loss of cell polarity.8
EPSC as biomarkers and opportunities 
for therapeutic intervention
Fuxe et al. review the many EMT associated 
factors like Snail and AP1 family members 
that have been shown to participate in EPSC.5 
A challenge for future studies is to deter-
mine which particular EPSC are formed in a 
spatio-temporal manner and which specific 
steps of EMT are regulated by distinct EPSC. 
importantly, these results require verification in 
animal models and biopsies of cancer patients. 
Ultimately, EPSC may associate with disease 
progression and poor prognosis and may be 
used as biomarkers to stratify cancer patients. 
in addition, EPSC may be a potential entry 
point for the development of therapies for can-
cer patients; domain mapping of Smad-protein 
interactions in EPSC can be used for devel-
opment of small molecular compounds that 
disrupt functional EPSC. Current strategies to 
inhibit TGF-β-induced invasion and metastasis 
target TGF-β ligand or TGF-β receptor are prone 
to have side effects; TGF-β is a highly pleiotro-
pic cytokine and has a dual role in cancer and 
other patho-physiological processes.9 Specific 
interference of EPSC holds promise to block 
tumor cell invasion and metastasis, while leav-
ing other TGF-β signaling arms largely intact.  
Figure 1. During the epithelial to mesenchymal transition (EMT) cells loose polarity and adopt 
properties required for motility and invasiveness. The EMT process (depicted by arrows) is 
stimulated by a combination of TGF-β and stem cell pathways. Characteristic is the dediffer-
entiation and loss of E-cadherin at the cell membrane. 
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Discovery that polyploid cells can undergo mitosis 
Comment on: Leysi-Derilou Y, et al. Cell Cycle 2010; 9:2589–99.
Yuan Gao and Diane S. Krause; Yale University; New Haven, CT USA; Email: diane.krause@yale.edu
Leysi-Derilou et al. in the laboratory of Nicolas 
Pineault show for the first time that polyploid 
megakaryocytes (MKs) are capable of under-
going mitosis. MKs are hematopoietic cells 
that give rise to platelets. MK maturation is 
marked by a progressive increase in ploidy 
(up to 128N) due to repeated DNA replication 
without cell division, a process termed endo-
mitosis, resulting in a large multilobulated, 
polyploid nucleus.1 Although the impact of 
polyploidization during MK maturation is not 
fully understood, it is generally considered 
that polyploidization is essential for efficient 
platelet production by MKs. Genes related to 
platelet production are upregulated in highly 
polyploid MKs.2 
Prior time-lapse microscopy studies char-
acterized endomitosis from the 2N to 4N stage 
as an aborted mitosis with failure at a late 
stage of cytokinesis.3-5 During anaphase, endo-
mitotic cells form normal central spindles, and 
the cleavage furrow nearly completes ingres-
sion, but the cells do not undergo abscission, 
leading to regression of the cleavage furrow 
to produce polyploid cells. The reasons for 
this aborted cytokinesies have begun to be 
elucidated. Polyploid endomitotic MKs form 
intact midzone structures with normal local-
ization of essential components of mitosis 
such as Survivin, Aurora B, iNCENP, PRC1 (pro-
tein regulating cytokinesis 1), MKLP1 and 2 
(mitotic kinesin-like protein), MgcRacGAP and 
microtubules.4,6 However, in contrast to normal 
cytokinesis, the contractile ring of MK under-
going endomitosis lacks non muscle myosin 
iiA and has decreased levels of RhoA and 
actin.4 RhoA signaling is required for estab-
lishing the actomyosin ring at the cleavage 
furrow, and generating the contractile force 
for completion of cytokinesis. Thus, decreased 
Rho/Rock signaling at the contractile ring may 
cause failure of late cytokinesis leading to 
endomitosis.
To gain greater insight into MK differentia-
tion and endomitosis, Leysi-Derilou, et al., used 
live cell imaging to track the formation and 
fate of polyploid human MKs derived in vitro 
for 5—10 days from cord blood (CB) and bone 
marrow (BM) CD34+ cells.7 They established 
methods to determine the ploidy level of MKs 
by combining cell history, cell size and Hoechst 
nuclear staining. These approaches enabled 
them to observe low-incidence events as they 
followed the fate of over 2000 polyploid MKs. 
Their data confirm that endomitosis is a fail-
ure of mitosis at cytokinesis; all visualized 
endomitotic events showed cleavage furrow 
formation and subsequent regression. More 
importantly, they report that polyploid MKs 
occasionally do complete cytokinesis and 
divide into separate daughter cells, although 
this happens significantly more often in MKs 
from CB than from BM (16% vs. 1.6% of 8N 
divisions result in complete cytokinesis in CB 
vs. BM, respectively). Division of 8N polyploid 
cells could be symmetric (most) or asym-
metric (rare), the latter giving rise to 2 MKs 
(2N and 6N), or even to 3 MKs (4N, 2N and 
2N). Although the 2N daughter cells usually 
die soon after cytokinesis, the higher ploidy 
daughter cells are viable and maintain the 
ability to undergo subsequent endomitotic 
events. The cell death in resulting 2N cells 
may be due to an abnormal distrubution of 
the homologous chromosomes, which are not 
split evenly between the daughter cells. in pre-
vious time-lapse studies, only an endomitotic 
fate was observed for polyploid MKs. This dis-
crepancy may have occurred because previous 
studies recorded polyploid MKs during a 6-24 
hour period, and tracked fewer than 50 poly-
ploid MKs undergoing endomitosis.3-5 Also, 
these studies used BM-derived MKs, which 
undergo cytokinesis more rarely than CB. Our 
lab has also observed polyploid cell division 
when the human erythroleukemia (HEL) cell 
line stably expressing H2B-GFP undergoes 
TPA induced megakaryocytic differentiation as 
recorded by fluorescence time-lapse micros-
copy. This novel finding is reminiscent of the 
recent discovery that platelets themselves are 
capable of division (analogous to cytokinesis) 
to form multiple functional platelets after they 
are released into the blood stream.8 
Whether polyploid divisions of MKs are an 
in vitro culture artifact or have physiological 
relevance for megakaryocytopoiesis in vivo 
remains to be investigated. One step to clar-
ify this would be to determine whether the 
small 6N peak observed occasionally in fresh 
BM samples from humans and mice by con-
ventional flow cytometry methods is due to 
individual 6N cells or caused by doublets of 
2N and 4N cells. This can be achieved using 
imagestream flow cytometry, which allows 
imaging and analysis of DNA content on thou-
sands of individual cells.
The data present suggest that primary poly-
ploid MKs divide and thereby contribute to the 
expansion of polyploid MKs. Explorations into 
the etiology of the differences in polyploid 
divisions between CB and BM derived MKs 
may lead to a better understanding of endomi-
tosis and megakaryocytopoiesis. 
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Histone acetylation gets complicated 
Comment on: Gatta R, et al. Cell Cycle 2010; 9:2149–59
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The highly dynamic structure of chromatin in 
eukaryotic cells allows compaction of DNA, 
regulation of gene expression and cell cycle 
progression at the same time. The combina-
tion of several post translational modifications 
(PTMs) of histones, as the “histone code” model 
suggests, specifies different chromatin states 
affecting all DNA related processes. Among 
the different modifications, up to present, 
acetylation seemed to be the easiest to inter-
pret since it correlates with opened chromatin 
structure.1 Even though multiple acetylation 
sites, deposited by several histone acetyl trans-
ferases [HATs; also called Lysine(K) acetyltrans-
ferases, KATs 2], have been identified both on 
the N-terminal tails and in the core domains 
of histones, these modifications were always 
associated with active transcription in inter-
phase cells.3,4 in S phase the epigenetic state of 
the cell is challenged as the chromatin under-
goes a wave of disruption and subsequent 
restoration during replication. Finally in M 
phase the chromatin reaches the highest level 
of compaction in the form of mitotic chro-
mosomes.5 Several DNA regions need to be 
transcribed during each cell cycle step, which 
might counteract the condensation required 
for the given cell cycle phase.6 The exact pro-
cesses ensuring active chromatin state in these 
conditions remain unknown. Acetylation is an 
unstable mark removed by histone deacety-
lases (HDACs), thus the controlled action of 
the opposing activities of HATs and HDACs is 
essential for proper regulation of both tran-
scription and cell cycle.5,7
The article published by R. Gatta and R. 
Mantovani in Cell Cycle challenges our view 
on histone acetylation and shows that it 
can anti-correlate with gene expression.8 
Using a modified ChiP protocol, allowing 
single nucleosome resolution, the authors 
provide evidence that several acetylation 
marks (H3K9, H3K18, and H2BK120) are 
present at the transcription start site 
and/or at the transcribed region of cell cycle 
regulated genes, such as PCNA and CyclinB2, 
during the repressed state. Their results high-
light that a switch of histone marks including 
actetylations, methylations and ubiquitination 
take place at cell cycle promoters when the 
corresponding genes turn on or off. A genome 
wide ChiP-Seq analysis of histone PTMs in syn-
chronized cell populations would enlarge our 
knowledge on how the cell phase-dependent 
transcriptome is established. Cell cycling, in 
this respect, has the unique feature that genes 
are constantly turned on and off as the cell 
progresses. This is in contrast with differentia-
tion, where, starting from a pluripotent stage, 
lineage specific genes get silenced or turn on 
for the rest of the cells’ fate. Switches similar to 
cell cycle can be envisaged in stress response, 
where the responsive genes have to turn on 
to overcome the stress situation and then get 
silenced once the cell returns to non-stressed 
conditions. Although histone PTMs have been 
mapped following gene expression changes 
during hematopoetic differentiation,9 until 
now not much is known about the role of 
acetylation in such a system. At the same time, 
global histone acetylation marks clearly shift 
during differentiation, as it has been shown for 
histone H4 in human embryonic stem cells.10
Another intriguing question raised by the 
authors is the possibility of cell cycle-depen-
dent action of HATs on promoters. They pro-
vide evidence that GCN5/KAT2A, the founding 
member of a family of HAT enzymes,11 is pres-
ent on the PCNA promoter exclusively when 
the gene is expressed.8 On the other hand, 
GCN5/KAT2A is recruited to the chromatin 
around the promoter of CyclinB2 during its 
“off” state, suggesting a role in repression.8 
Consequently, the same HAT seems to be able 
to activate a set of genes and repress others. 
Clearly, the picture is more complicated than it 
seems, as in vertebrate cells GNC5/KAT2A and 
PCAF/KAT2B, two highly identical HATs, coex-
ist.11 Moreover, both enzymes are components 
of at least two multisubunit complexes; SAGA 
and ATAC.12 Many questions remain opened: 
(1) what is the role of the different acetylation 
marks in combination with other histone PTMs 
at a genome wide level; (2) is the effect of acet-
ylation locus specific; (3) which HATs deposit 
this mark, are they strictly specific or do their 
activities overlap; (4) which HDACs remove the 
acetyl group when it is no longer required; (5) 
as these enzymes do not exert their function 
alone in the cell, into what complex they are 
incorporated to impact a genomic locus at a 
given stage. The observations reported by the 
Mantovani group provide a first step to answer 
these questions.8 Future experiments will shed 
light on the exact role of HATs and the marks 
they deposit on the genome during transcrip-
tional changes in the context of cell cycle.
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